1. Home
  2. AADI vs VSTE Comparison

AADI vs VSTE Comparison

Compare AADI & VSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • VSTE
  • Stock Information
  • Founded
  • AADI 2011
  • VSTE 2009
  • Country
  • AADI United States
  • VSTE Australia
  • Employees
  • AADI N/A
  • VSTE N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • VSTE
  • Sector
  • AADI Health Care
  • VSTE
  • Exchange
  • AADI Nasdaq
  • VSTE Nasdaq
  • Market Cap
  • AADI 59.4M
  • VSTE 51.9M
  • IPO Year
  • AADI N/A
  • VSTE N/A
  • Fundamental
  • Price
  • AADI $2.34
  • VSTE $1.60
  • Analyst Decision
  • AADI Hold
  • VSTE
  • Analyst Count
  • AADI 3
  • VSTE 0
  • Target Price
  • AADI $1.75
  • VSTE N/A
  • AVG Volume (30 Days)
  • AADI 109.6K
  • VSTE 2.7M
  • Earning Date
  • AADI 11-06-2024
  • VSTE 01-01-0001
  • Dividend Yield
  • AADI N/A
  • VSTE N/A
  • EPS Growth
  • AADI N/A
  • VSTE N/A
  • EPS
  • AADI N/A
  • VSTE N/A
  • Revenue
  • AADI $25,070,000.00
  • VSTE $342,000.00
  • Revenue This Year
  • AADI $9.39
  • VSTE N/A
  • Revenue Next Year
  • AADI $6.15
  • VSTE N/A
  • P/E Ratio
  • AADI N/A
  • VSTE N/A
  • Revenue Growth
  • AADI 7.80
  • VSTE N/A
  • 52 Week Low
  • AADI $1.21
  • VSTE $0.83
  • 52 Week High
  • AADI $2.63
  • VSTE $11.99
  • Technical
  • Relative Strength Index (RSI)
  • AADI 58.75
  • VSTE 53.84
  • Support Level
  • AADI $2.25
  • VSTE $1.30
  • Resistance Level
  • AADI $2.45
  • VSTE $1.44
  • Average True Range (ATR)
  • AADI 0.11
  • VSTE 0.22
  • MACD
  • AADI -0.01
  • VSTE -0.00
  • Stochastic Oscillator
  • AADI 39.89
  • VSTE 59.36

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About VSTE Vast Renewables Limited

Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.

Share on Social Networks: